Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
To release full third quarter 2025 financial results on November 13th; conference call to follow TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company t
(Financial Post, 2025-10-07T11:45:31Z)